Peter Marks is an American hematologist and oncologist who currently serves as the head of infectious disease and senior vice president of molecule discovery at Eli Lilly. He previously served as the director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, having been appointed to the position in 2016 after previously serving as deputy director. Among other duties, Marks oversaw the FDA vaccine program. In March 2025, Marks resigned from his position.
- Occupation
- medical researcher
- Position held
- director
